123 related articles for article (PubMed ID: 24759894)
41. [Practical guides for stopping the tobacco habit: a cost-effectiveness analysis?].
Pérez Trullén A; Sánchez Agudo L
Arch Bronconeumol; 1999 May; 35 Suppl 3():89-94. PubMed ID: 10410233
[No Abstract] [Full Text] [Related]
42. Smoking-still trying to kick the habit.
The Lancet Respiratory Medicine
Lancet Respir Med; 2013 May; 1(3):175. PubMed ID: 24429110
[No Abstract] [Full Text] [Related]
43. Tobacco tax and Maori and low-income families.
Thomson G; Wilson N
N Z Med J; 2000 May; 113(1110):197. PubMed ID: 10917088
[No Abstract] [Full Text] [Related]
44. Public health focus: effectiveness of smoking-control strategies--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(35):645-7, 653. PubMed ID: 1508130
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
Boyd KA; Briggs AH
Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of varenicline for smoking cessation.
Keiding H
Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
[TBL] [Abstract][Full Text] [Related]
47. Why prevention can increase health-care spending.
Temple NJ
Eur J Public Health; 2012 Oct; 22(5):618-9. PubMed ID: 21914705
[TBL] [Abstract][Full Text] [Related]
48. School smoking bans.
Walsh RA; Paul CL
Drug Alcohol Rev; 2008 Sep; 27(5):570-1. PubMed ID: 18696303
[No Abstract] [Full Text] [Related]
49. Spending decisions for tobacco-related disease treatment and tobacco control: an example and a solution.
Thomson G; Wilson N
N Z Med J; 2005 Feb; 118(1210):U1337. PubMed ID: 15776107
[No Abstract] [Full Text] [Related]
50. Telephone smoking cessation intervention: the free and clear program.
Sofian NS; McAfee T; Wilson J; Levan S
HMO Pract; 1995 Sep; 9(3):144-6. PubMed ID: 10151100
[No Abstract] [Full Text] [Related]
51. [Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review].
Aumann I; Rozanski K; Damm K; Graf von der Schulenburg JM
Gesundheitswesen; 2016 Oct; 78(10):660-671. PubMed ID: 27784123
[No Abstract] [Full Text] [Related]
52. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
Bauld L; Boyd KA; Briggs AH; Chesterman J; Ferguson J; Judge K; Hiscock R
Nicotine Tob Res; 2011 Feb; 13(2):135-45. PubMed ID: 21196451
[TBL] [Abstract][Full Text] [Related]
53. Smoking cessation counseling: a practice management perspective.
Pohlig C
Chest; 2006 Oct; 130(4):1231-3. PubMed ID: 17035460
[TBL] [Abstract][Full Text] [Related]
54. The cost-effectiveness of call-back counselling for smoking cessation.
Lal A; Mihalopoulos C; Wallace A; Vos T
Tob Control; 2014 Sep; 23(5):437-42. PubMed ID: 23748188
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness of intensive smoking cessation therapy among patients with small abdominal aortic aneurysms.
Mani K; Wanhainen A; Lundkvist J; Lindström D
J Vasc Surg; 2011 Sep; 54(3):628-36. PubMed ID: 21620630
[TBL] [Abstract][Full Text] [Related]
56. Are comprehensive environmental changes as effective as health education for smoking cessation?
Kadowaki T; Kanda H; Watanabe M; Okayama A; Miyamatsu N; Okamura T; Hayakawa T; Hishida K; Kita Y; Ueshima H
Tob Control; 2006 Feb; 15(1):26-9. PubMed ID: 16436400
[TBL] [Abstract][Full Text] [Related]
57. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
von Wartburg M; Raymond V; Paradis PE
Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.
Croghan IT; Offord KP; Evans RW; Schmidt S; Gomez-Dahl LC; Schroeder DR; Patten CA; Hurt RD
Mayo Clin Proc; 1997 Oct; 72(10):917-24. PubMed ID: 9379693
[TBL] [Abstract][Full Text] [Related]
59. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame.
Cobiac LJ; Ikeda T; Nghiem N; Blakely T; Wilson N
Tob Control; 2015 Jun; 24(e2):e154-60. PubMed ID: 25145342
[TBL] [Abstract][Full Text] [Related]
60. The recent and projected public health and economic benefits of cigarette taxation in Greece.
Alpert HR; Vardavas CI; Chaloupka FJ; Vozikis A; Athanasakis K; Kyriopoulos I; Bertic M; Behrakis PK; Connolly GN
Tob Control; 2014 Sep; 23(5):452-4. PubMed ID: 23467654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
